On Thursday, Uganda confirmed an outbreak of the Ebola virus in its capital city Kampala, with the first confirmed patient dying from it a day before. As per the new developments, the officials are now preparing to deploy a trial vaccine to put an end to this outbreak.
Groups of scientists are working on the vaccine and deployment of more than 2,000 doses of a candidate vaccine against the Sudan strain of Ebola has been planned and confirmed by the Uganda Virus Research Institute. As per the World Health Organization (WHO), Uganda has access to 2,169 doses of trial vaccine. For now, however, there are no approved vaccines for the strain and officials are still investigating the source of the outbreak.
The WHO had also allocated $1 million from its contingency fund for emergencies to support quick action and contain the outbreak in the country.
On Wednesday, the Sudan strain of Ebola killed a nurse employed at Kampala's main referral hospital. It is after his death that Ebola was declared an outbreak in the country. Post-mortem samples too have confirmed the Sudan Ebola Virus Disease and at least 44 contacts of the deceased man have been listed for tracing. 30 of these are health workers.
Ebola is a highly infectious hemorrhagic fever, which is transmitted through contact with bodily fluids and tissue. Symptoms include headache, vomiting of blood, muscle pains and bleeding.
it was in the late 2022, when Uganda had last suffered an Ebola outbreak. It killed 55 of the 143 people who were infected and was declared over on January 11, 2023.
As per the WHO, Ebola virus disease (EVD) is a rare but severe illness in humans and is often fatal. People can get infected with the virus if they touch an infected animal when preparing food, or touch body fluids of an infected person such as saliva, urine, faeces or semen, or things that have body fluids of an infected person like clothes or sheets.
Ebola enters the body through cuts in the skin or when one is touching their eyes, nose or mouth. Early symptoms include fever, fatigue and headache.
It was first discovered in 1976 in two simultaneous outbreak, when in Nzara, South Sudan and other in Yambuku, Democratic Republic of Congo. The latter occurred near a village near the Ebola River, which is where it gets its name from.
It is highly infectious and transmissible disease, in fact, there have been cases of health-care workers who have frequently been infected while treating patients with suspected or confirmed Ebola. This occurs through close contact with patients when infection control precautions are not practiced strictly.
Cases of people conducted burial ceremonies, involving direct contact with the body of the deceased too can lead to the transmission of Ebola. Even after the long suffering and recovery, there is a possibility of sexual transmission. Pregnant women who get acute Ebola and recover may still carry the virus in their breastmilk, or in pregnancy related fluids and tissues.
Credit: iStock
The NHS in England today announced that 100 pharmacies will offer free cholesterol check-ups beginning this autumn.
The initiative is part of an NHS drive to reduce heart disease and stroke deaths by a quarter over the next decade. It will include free finger-prick blood tests for cholesterol on the high street for the first time.
People aged 40 to 84 who are not pregnant and have not had a blood test in the past year will be eligible to walk in and get tested.
Eligible people will also be offered a blood pressure check as part of a clinical consultation with a pharmacist prescriber.
The NHS pilot will run until spring 2027.
Blood will be taken from a person’s fingertip using a lancet — a small, sharp medical tool used to prick the skin — and analyzed immediately. A pharmacist prescriber can then provide lifestyle advice and determine whether any treatment, such as statins, may be needed.
Patients will receive a copy of their results by email. They will also be offered a blood pressure check as part of a clinical consultation with a pharmacist prescriber.
The national rollout follows a successful smaller pilot in north London, which tested 2,493 patients at 61 community pharmacies between January 2025 and March 2026.
Nearly one in five patients were found to be suitable for pharmacological intervention, and 88 people started taking statins.
David Webb, the chief pharmaceutical officer for England, said pharmacies could be a vital first line of defense against serious illness.
He said: “By making it easier for people to get a quick and convenient cholesterol health check on their local high street, we can spot ticking timebombs earlier, helping people take action, and prevent heart attacks and strokes before they happen.
“This is the latest in a series of initiatives involving pharmacies in delivering care previously only offered in GP surgeries as part of the 10-year health plan to bring care closer to where people live.”
In the first phase of the national rollout, about 100 NHS pharmacies across England will begin offering the checks from this autumn.
Dr Rani Khatib, NHS England’s national specialty adviser for cardiovascular disease prevention, said everyone should strive to be aware of the most common risk factors for heart disease, including high cholesterol and blood pressure, and “know their numbers”.
“This initiative will help people manage their risk factors earlier and reduce their risk of having heart attacks or strokes,” he said.
Alison McGovern, a health minister, said it was “exactly the type of innovation” she wanted to see across the NHS.
“We’re making it easier for people to spot potential problems earlier and take action to protect their health,” she said.
“Early detection can help prevent serious conditions such as heart attacks and strokes, helping people stay healthier for longer while reducing pressure on NHS services.”
Too much LDL (“bad”) cholesterol in the blood can build up inside artery walls. Over time, these fatty deposits — called plaque or atheroma — can make arteries narrower and restrict blood flow, according to the NHS.
High cholesterol usually causes no symptoms, which is why testing is important. Cholesterol can be reduced through healthier eating and regular exercise and, for people at sufficient risk, medicines such as statins.
Credit: iStock
Amid declining childhood vaccination rates and an anti-vaccine push from the government, the US is reporting a significant uptick in measles cases in three more states.
The states include Pennsylvania, Wisconsin, and Georgia. Pennsylvania has also reported two deaths, including an Amish newborn, marking 2026’s first measles-related deaths in the country.
Two unvaccinated individuals, including a newborn infant, died, marking the first measles-associated deaths in the state in 35 years.
Also read: Measles: Infant Among Two Unvaccinated Deaths Reported In US
According to the Centers for Disease Control and Prevention, 2,903 confirmed cases had been reported nationwide as of August 27, threatening the US measles-elimination status held since 2000.
About 94% of cases are among unvaccinated people, and children under 5 account for 19% of cases.
This is the highest number of cases reported since the major resurgence between 1989 and 1991, when 55,000 infections and 123 deaths were recorded.
In comparison, for the full year 2025, the country reported 2,289 cases and three deaths.
While two doses of the MMR vaccine are key to preventing measles, the highly contagious virus, the first MMR dose is recommended at 12 to 15 months, followed by a second dose at 4 to 6 years.
The anti-vaccine stance promoted by the Trump-led US government and HHS Secretary RFK Jr. comes as cases are spiraling. More recently, Trump also announced a split of the MMR vaccine.
Measles is a serious and highly contagious illness that can be particularly dangerous for babies and young children. The best way to prevent measles is to get vaccinated.
The measles, mumps and rubella (MMR) vaccine is a safe and effective way to protect yourself and others from this dangerous disease.
Measles is more than just a simple rash and can lead to severe health problems and, in some cases, death.
The first signs of measles often mimic a common cold. These initial symptoms include a high fever that can reach over 104°F, a persistent cough, a runny nose, and red, watery eyes.
These symptoms can be misleading, but their combination is a key indicator of the onset of measles.
A distinctive sign of measles is the appearance of tiny white spots, called Koplik spots, inside the mouth. These spots typically develop two to three days after the initial symptoms begin.
Their presence is an important diagnostic clue, often appearing before the characteristic measles rash.
A rash appears three to five days after the initial symptoms. It usually starts as flat red spots on the face, near the hairline, and then spreads downward to the neck, trunk, arms, legs and feet.
The spots can sometimes be slightly raised and may merge. When the rash appears, the fever may also increase significantly.
While measles can be serious for anyone, certain groups are at a higher risk of developing complications. These include:
Credit: AI
A chemistry lab at the Massachusetts Institute of Technology (MIT) was shut down and subjected to hazardous-material testing after a graduate student revealed that they may have synthesised dimethylmercury, an extremely toxic form of organic mercury.
The student went to an emergency department after reporting the possible exposure. MIT said the student was not authorised to work with dimethylmercury and that the chemical was not part of their research.
Since the incident, Building 18 has been closed for testing and decontamination, while precautionary cleaning has also been carried out in the student's residence hall.
Even though the student remained under medical supervision, MIT later said that the student's initial blood test showed no sign of mercury exposure. So, why did a slight possibility of this chemical trigger such a major response?
Unlike some toxic substances that mainly become dangerous when swallowed or inhaled, dimethylmercury can be absorbed through the skin. Its exposure routes include inhalation, ingestion and absorption through skin. Additionally, its ability to pass through protective materials is one reason laboratory safety experts have historically treated it with extreme caution.
The US Occupational Safety and Health Administration says dimethylmercury is “readily absorbed through the skin” and warns that a severe toxic dose can involve less than 0.1 mL of the liquid.
The danger comes partly from the molecule's physical and chemical properties. Dimethylmercury is lipid-soluble to break biological barriers and enter the body efficiently. Once absorbed, mercury can ultimately reach the nervous system and cause severe and irreversible neurological damage.
It is also extremely volatile, meaning its exposure is not limited to direct skin contact. It can also generate toxic vapour that one may inhale and get poisoned. Once poisoned, the effects can be deceptive because symptoms may not appear immediately.
That delay can make even a minor exposure especially dangerous as the person may not realise they have been poisoned until significant neurological damage has occurred.
Also read: How To Get Rid Of Heavy Metals In Your Body?
Dimethylmercury is even more dangerous as it is capable to enter the body efficiently, producing delayed neurological toxicity.
Researchers and safety authorities therefore treat even a slight exposure as an emergency rather than waiting for symptoms to develop.
The chemical's notorious reputation was further cemented after the death of Karen Wetterhahn, a chemistry professor at Dartmouth College.
In 1996, Wetterhahn accidentally spilled a very small amount of dimethylmercury onto her gloved hand. At the time, she was wearing latex gloves that were considered adequate laboratory protection. But the chemical penetrated the gloves and was absorbed through her skin.
Months later, she developed neurological symptoms including problems with balance and speech. She was diagnosed with severe mercury poisoning and died in 1997.
The case led laboratories to reconsider how dimethylmercury should be handled and highlighted the inadequacy of ordinary latex gloves against the chemical.
© $2026 Times Horizon Private Limited